Impact of different pack sizes of paracetamol in the United Kingdom and Ireland on intentional overdoses: a comparative study

Hawton, Keith; Bergen, Helen; Simkin, Sue; Arensman, Ella; Corcoran, Paul; Cooper, Jayne; Waters, Keith; Gunnell, David; Kapur, Navneet
January 2011
BMC Public Health;2011 Supplement 4, Vol. 11 Issue Suppl 4, p460
Academic Journal
Background: In order to reduce fatal self-poisoning legislation was introduced in the UK in 1998 to restrict pack sizes of paracetamol sold in pharmacies (maximum 32 tablets) and non-pharmacy outlets (maximum 16 tablets), and in Ireland in 2001, but with smaller maximum pack sizes (24 and 12 tablets). Our aim was to determine whether this resulted in smaller overdoses of paracetamol in Ireland compared with the UK. Methods: We used data on general hospital presentations for non-fatal self-harm for 2002 - 2007 from the Multicentre Study of Self-harm in England (six hospitals), and from the National Registry of Deliberate Self-harm in Ireland. We compared sizes of overdoses of paracetamol in the two settings. Results: There were clear peaks in numbers of non-fatal overdoses, associated with maximum pack sizes of paracetamol in pharmacy and non-pharmacy outlets in both England and Ireland. Significantly more pack equivalents (based on maximum non-pharmacy pack sizes) were used in overdoses in Ireland (mean 2.63, 95% CI 2.57-2.69) compared with England (2.07, 95% CI 2.03-2.10). The overall size of overdoses did not differ significantly between England (median 22, interquartile range (IQR) 15-32) and Ireland (median 24, IQR 12-36). Conclusions: The difference in paracetamol pack size legislation between England and Ireland does not appear to have resulted in a major difference in sizes of overdoses. This is because more pack equivalents are taken in overdoses in Ireland, possibly reflecting differing enforcement of sales advice. Differences in access to clinical services may also be relevant.


Related Articles

  • Evolving responsibilities in pharmacy. BRUSHWOOD, DAVID B. // Pharmacy Today;Apr2015, Vol. 21 Issue 4, p65 

    The article discusses significance of responsibilities of pharmacists in serving the patients, focusing on judicial procedures in the U.S. related to pharmacy professionals. It cites a court case in Florida wherein a woman sued a pharmacy that allegedly provided medicines such as...

  • Enhancing Student Advocacy by Broadening Perspective. Beardsley, Robert S. // American Journal of Pharmaceutical Education;Feb2004, Vol. 68 Issue 1, p1 

    Reports on enhancing the student advocacy by increasing involvement of the schools and colleges. Use of student chapters of national pharmacy organizations for presenting contemporary pharmacy issues; Need for leadership development programs for effective work by the organizations; Strength to...

  • PILL SPLITTING: A HALF-BAKED IDEA? Magill-Lewis, Jillene // Drug Topics;11/5/2001, Vol. 145 Issue 21, p30 

    Comments on the pill splitting proposal of pharmacists in the United States. Discussion on the administration and proper dosage of drugs; Cost of prescription drugs; Regulations imposed under the pharmacy law.

  • Congress approves drug coverage and funding. Wechsler, Jill // Managed Healthcare;Aug2000, Vol. 10 Issue 8, p18 

    Reports that Republicans in the United States House of Representatives have approved a prescription drug benefit. Pressure to increase consumer access to needed medicines; Proposal to boost payments to Medicare+Choice plans; Establishment of Medicare prescription drug plans.

  • HIGH COURT DEFENDS OFF-LABEL PROMOTION. Dickinson, James G. // Medical Marketing & Media;Jun2002, Vol. 37 Issue 6, p14 

    Focuses on the federal court's decision on off-label drug promotions in the U.S. Support for the compounding pharmacists' free-speech rights; Revisions made to the Food and Drug Administration's restrictions on commercial speech; Emphasis promoting methods to protect public health.

  • Pharmacy Compounding: Customizing Drugs. Nordenberg, Tamar // Consumers' Research Magazine;Sep2000, Vol. 83 Issue 9, p22 

    Discusses the pharmacy-compounding law in the United States. Objective of the law; Reaction of health professionals to the law; Drawbacks of the law. INSET: The Law Laid Out..

  • Foreign pharmacy owners attack planned limits. Csonka, Agnes // Budapest Business Journal;9/10/2001, Vol. 9 Issue 41 

    Reports on a proposed amendment to the Pharmacy Law in Hungary. Limitation of the stakes of foreign owners of pharmacy chains; Market controlled by foreign-owned pharmacy chains.

  • Mainers need not apply.  // Drug Topics;10/10/94, Vol. 138 Issue 19, p7 

    Reports that the state of Maine has been excluded from the rebate program for Miles' calcium-channel blocker due to state legislation on unitary pharmacy pricing.

  • Discriminatory pricing update. Conlan, Michael F. // Drug Topics;4/10/95, Vol. 139 Issue 7, p54 

    Provides an update on developments related to the pharmaceutical industry of the United States for the week ending April 10, 1995. Legislative battle over equal access to pharmaceutical discounts; Arizona pharmacists' efforts to create a bill that would establish another classification of...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics